Browsing: Longevity

Survey finds C-suite sentiment improving, dealmaking rebounding, and hiring plans warming, even as the FDA clouds the outlook. Biotech executives…

Texas A&M study shows small, consistent physical activity can reduce dementia risk in older adults with mild cognitive impairment. A…

Sun Pharma can manufacture and export, but the Delhi High Court bars Indian sales until Novo Nordisk’s patent expires in…

With new investor backing, the company prepares a £25m Series A to move its lead tauC3 antibody into human trials.…

Targeted nutrient transport is gaining traction as DHA delivery research moves from mechanism to real-world market application. The brain is…

Researchers have investigated the reporting quality of preclinical studies’ outcomes in anti-aging research. They analyzed how study quality changed over…

OpenAI-backed Chai Discovery lands $130m, claiming “100-fold improvement” over previous computational design methods. AI-native drug discovery platform Chai Discovery has…

Bets on automation underscore investor confidence in industrializing cell therapies as patient demand continues to outpace supply. Cellular Origins, a…

Phase III trial shows up to 28.7% weight loss, but tolerability remains a key concern for Eli Lilly’s triple-agonist therapy.…

New health platform converts labs, wearables and records into personalized plans designed to close the gap between insight and action.…